Napoli's Osimhen completes €75mil move to Galatasaray
ISTANBUL : Napoli striker Victor Osimhen on Thursday completed his permanent move to Turkish champions Galatasaray in a €75 million (US$87.5 million) four-year deal.
A key figure in Napoli's 2023 title triumph, Osimhen spent last season on loan at Galatasaray, scoring 26 goals in 30 league games as the Istanbul club claimed their 25th Super Lig crown.
He was absent as Napoli, the freshly crowned Serie A champions, resumed training at the start of the week as the finer details of the deal were concluded.
Napoli coach Antonio Conte seemingly did not have the 26-year-old in his plans for his side's Scudetto defence next term.
Negotiations with Galatasaray had been ongoing for several weeks but up to Thursday had stalled over the terms of payment for the transfer.
Napoli recently recruited Kevin De Bruyne from Premier League club Manchester City.
Osimhen becomes Galatasaray's most expensive ever player.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
8 hours ago
- Malay Mail
Pfizer Romania recognized as a Best Place to Work for 2025
Leadership & Trust 94% of employees say leaders respect labor laws 89% believe leaders act with integrity and ethics 86% agree leadership communicates a clear and inspiring vision Culture of Inclusion 94% say differences (gender, ethnicity, age) do not affect how people are treated 90% feel their ideas and opinions are respected 91% say integrity is a shared value across teams Managerial Support 93% say their manager upholds ethical standards 90% feel supported in health and well-being 88% receive meaningful feedback to grow Engagement & Purpose 86% overall employee satisfaction 86% align with Pfizer's commitment to social responsibility 83% rate HR practices as people-focused 94% alignment with best practices in people-focused HR policies 90% alignment in leadership support and strategic direction 89% alignment in employee engagement initiatives 88% alignment in teamwork and cross-functional collaboration 81% alignment with best practices in benefits programs 73% alignment in compensation structures and fairness 93% alignment in community involvement and corporate social responsibility, reinforcing Pfizer's strong commitment to societal impact BUCHAREST, ROMANIA - Media OutReach Newswire - 6 August 2025 - Pfizer Romania has been officially certified as one of the, a recognition that highlights its commitment to fostering a workplace culture grounded in integrity, inclusion, and employee is a leading international certification that honors organizations providing exceptional employee experiences. The evaluation combines anonymous employee feedback with a comprehensive HR assessment, measuring areas such as leadership, culture, well-being, growth opportunities, and people Romania's certification was driven by impressive scores across key dimensions of workplace culture. According to the internal employee survey:In addition to the strong employee feedback,, which benchmarks the company's practices against recognized global standards. The results reflect how closely Pfizer Romania's approach aligns with best-in-class HR practices across multiple areas:said, General Manager of Pfizer Romania., Senior Manager, People Experience, added:Hashtag: #BestPlacesToWork The issuer is solely responsible for the content of this announcement. About Pfizer Romania Pfizer Romania, a subsidiary of Pfizer Inc., has been serving Romanian communities for over 30 years, delivering innovative medicines and vaccines across multiple therapeutic areas. Guided by the global mission "Breakthroughs that change patients' lives," the company collaborates closely with healthcare providers and institutions to expand access to quality healthcare and advance public health outcomes. About the Best Places to Work Program Best Places to Work is a global HR certification program that identifies leading employers around the world. The certification process includes a rigorous evaluation of workplace culture through employee surveys and an audit of HR practices across eight key areas, including leadership, well-being, inclusion, and career development. Learn more at: LinkedIn: Best Places to Work
Malay Mail
10 hours ago
- Malay Mail
Rhenus Group Announces Key Leadership Appointments in the Air & Ocean Division to Drive Global Growth
Joachim Hanssen appointed Chief Executive Officer, Asia Pacific (APAC), effective August 1, 2025 Alberto Martinez appointed Chief Executive Officer, Europe (EU), effective October 1, 2025 Renee Toh to succeed Martinez as Vice President Global Ocean Freight, effective September 25, 2025 SINGAPORE - Media OutReach Newswire - 6 August 2025 - The Rhenus Group today announced three strategic leadership appointments that will play a pivotal role in driving the company's next phase of growth, innovation, and regional appointments are part of a broader transformation within the Air & Ocean division of the Rhenus Group, aimed at aligning leadership with evolving market dynamics and strengthening the company's ability to deliver customer-centric solutions across key geographies. Joachim Hanssen Appointed Chief Executive Officer, Asia Pacific (APAC) Effective August 1, 2025, Joachim Hanssen has assumed the role of Chief Executive Officer, Asia Pacific (APAC). Joachim will also oversee Greater China, Central Asia & Turkey as part of his scope of work. With over two decades at Rhenus, Joachim has been instrumental in expanding the company's footprint across Asia. His leadership has been marked by operational excellence, cultural fluency, and a strong focus on regional growth. Joachim's appointment positions Rhenus to unify and scale its APAC operations with greater strategic cohesion. Alberto Martinez Appointed Chief Executive Officer, Europe (EU) Effective October 1, 2025, Alberto Martinez will take on the role of Chief Executive Officer, Europe (EU). Currently serving as Vice President Global Ocean Freight, Alberto has led the development of Rhenus' global ocean freight strategy, expanded trade lanes, and built strong carrier partnerships. His leadership has built up a global ocean freight structure, driven commercial growth and strengthened Rhenus' position as a global ocean freight forwarder. Alberto is well positioned to lead the European region, one of Rhenus' most complex and strategically vital markets, into the next phase of development. Alberto will succeed Markus Lingohr, who will retire in 2026, with a structured transition already underway. Renee Toh to Lead Global Ocean Freight Rhenus is pleased to announce the appointment of Renee Toh as Vice President Global Ocean Freight, effective September 25, 2025, succeeding Alberto brings over 20 years of global experience in ocean freight and trade management, with a strong track record in leading cross-functional teams and delivering commercially driven solutions. Prior to joining Rhenus, she covered the position as Head of Global Ocean Freight Procurement at CEVA Logistics, where she played a key role in optimizing procurement strategies and enhancing global carrier appointment underscores Rhenus' commitment to strengthening its global product strategy and enhancing service delivery across international trade lanes. Strategic Leadership for a Future-Ready Organization The newly appointed leaders bring deep expertise, global perspective, and proven track records in building high-performing teams and scalable logistics solutions. Their new roles reflect Rhenus Group's commitment to investing in leadership that can translate global strategy into regional execution."These leadership appointments reflect our long-term vision to build a more agile, integrated, and customer-focused organization. By placing experienced leaders in strategically critical roles, we are reinforcing our ability to respond to market shifts, deepen customer relationships, and unlock new opportunities across regions," said Jan Harnisch, Member of the Board – Air & Ocean. "Rhenus is pleased to announce the new appointments of Joachim and Alberto, and to welcome Renee as member of the Rhenus family, wishing each of them continued success and fulfillment in their respective roles. Their experience will be instrumental in driving our next phase of growth and integration across regions."Hashtag: #Rhenus The issuer is solely responsible for the content of this announcement. About Rhenus The Rhenus Group is one of the leading logistics specialists with global business operations and annual turnover amounting to EUR 8.2 billion. 41,000 employees work at 1,330 business sites in more than 70 countries and develop innovative solutions along the complete supply chain. Whether providing transport, warehousing, customs clearance or value-added services, the family-owned business pools its operations in various business units where the needs of customers are the major focus at all times.
Free Malaysia Today
10 hours ago
- Free Malaysia Today
Wegovy maker Novo Nordisk to reduce costs after US$95bil stock loss
Novo Nordisk's market cap has fallen since its peak to some US$212 billion. (EPA Images pic) COPENHAGEN : Wegovy-maker Novo Nordisk said today it will sharpen its commercial focus and reduce costs, after a major profit warning and new CEO announcement last week wiped some US$95 billion of value from the company's stock. The Danish drugmaker, which boomed to become Europe's most valuable firm worth some US$650 billion last year on the back of sales of its blockbuster weight-loss drug, is facing a pivotal moment as it battles rising competition that is denting sales. The company repeated its full-year guidance, days after slashing its 2025 sales outlook and replacing CEO Lars Fruergaard Jorgensen with veteran insider Maziar Mike Doustdar. Its market cap has fallen since its peak to some US$212 billion. 'We are taking measures to sharpen our commercial execution further, and ensure efficiencies in our cost base while continuing to invest in future growth,' outgoing CEO Jorgensen said in a statement. Doustdar will take the helm tomorrow, with the firm facing tough questions from investors about how it can stay competitive in the booming weight-loss drug market against US rival Eli Lilly and a wave of compounded copycat versions. Novo has been hit by copycats of its GLP-1 drugs Wegovy for weight-loss and Ozempic for diabetes. US law bars pharmacies from replicating approved drugs, but has allowed 'compounding' for patients needing custom doses or formulations. Novo reported second quarter (Q2) sales of DKK76.86 billion (US$11.92 billion), up 18% from last year, below analysts initial expectations. It confirmed a 2025 sales growth forecast of between 8% and 14%, which was cut in a profit warning last week from the previous 13%-21%. It was the second time this year that the company cut its sales forecast. The Q2 earnings before interest and taxation (Ebit) stood at DKK33.45 billion, up 29% from a year ago.
